Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
723 Lymph node-targeted AMP-vaccine enables tumor-directed mKRAS-specific immune responses with potent polyfunctional and cytolytic activity
Compose a Response to This Article
Other responses
No responses have been published for this article.
